First, during active acromegaly, when patients are exposed to supraphysiological GH and IGF-1 levels, there is increased endocortical turnover in the presence of an increased number of bone remodeling sites, but stable trabecular bone mass [7, 11]. The gene discussed is IGF1; the disease is acromegaly.